A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors
Seagen Inc.
Seagen Inc.
ViroMissile, Inc.
Erasca, Inc.
MacroGenics
City of Hope Medical Center
City of Hope Medical Center
Abramson Cancer Center at Penn Medicine
Actym Therapeutics, Inc.
Ikena Oncology
UNC Lineberger Comprehensive Cancer Center
Memgen, Inc.
Day One Biopharmaceuticals, Inc.
Novartis
DEKA Biosciences
Columbia University
BerGenBio ASA
ABM Therapeutics Corporation
Eli Lilly and Company
NGM Biopharmaceuticals, Inc
Eli Lilly and Company
NantBioScience, Inc.
Xencor, Inc.
Pfizer
ADC Therapeutics S.A.
Eli Lilly and Company
NGM Biopharmaceuticals, Inc
Celldex Therapeutics
Sumitomo Pharma America, Inc.
Fate Therapeutics
Xencor, Inc.
Quadriga Biosciences, Inc.
Genzada Pharmaceuticals USA, Inc.
Provectus Pharmaceuticals
Incyte Corporation
MacroGenics
Asana BioSciences
Lumos Pharma
Abramson Cancer Center at Penn Medicine
Tocagen Inc.
Isarna Therapeutics GmbH
sigma-tau i.f.r. S.p.A.
Mayo Clinic
Wake Forest University Health Sciences
Celgene
Threshold Pharmaceuticals
Santa Maria Biotherapeutics
OrienGene Biotechnology Ltd.
M.D. Anderson Cancer Center
BIND Therapeutics
City of Hope Medical Center